ResearchDx, Abreos Bio Partner on Test for MS, Crohn's Disease

Aug 30, 2018

|

NEW YORK (360Dx) – Abreos Biosciences today announced a collaboration with ResearchDx to make a test for monitoring Tysabri (natalizumab) available to clinicians and clinical trial partners.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

ResearchDx, Abreos Bio Partner on Test for MS, Crohn's Disease

To read the full story....

Breaking News

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

What's Popular?

Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib

Sponsorships